A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 188 participants.
Also called NCT04784442
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 188 participants
- Registry
-
NCT04784442
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT04784442. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-24 (actual); primary completion 2022-04-18 (actual). Results posted on 2024-03-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- 180mg of ETC-1002(bempedoic acid)
- Intervention (Drug)
- 120mg of ETC-1002(bempedoic acid)
- Intervention (Drug)
- 60mg of ETC-1002(bempedoic acid)
- Intervention (Drug)
- Placebo
- Lead sponsor
- Otsuka Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct04784442- Content hash
414c4b66f7177744881b4ddca2beeb3376ad45bb8974ff82708ef44d24fc4371